Argenx Secures CHMP Recommendation For European Approval Of VYVGART SC Injection For CIDP Treatment
28/4 07:15
(RTTNews) - argenx SE (ARGX) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended European Commission approval of VYVGART 1000mg (efgartigimod alfa). This subcutaneous (SC) injection is proposed as a monot...